Croda International ( (GB:CRDA) ) has shared an update.
Croda International reported a challenging yet transitional year for 2024, with sales slightly declining by 1% at constant currency, excluding Covid-19 lipid sales. Despite a decrease in operating profit and margin, the company showed resilience with strong cash flow and a slight increase in dividends. The Consumer Care segment showed robust growth driven by local and regional customers, while Life Sciences faced challenges due to the absence of Covid-19 lipid sales. Croda is focusing on innovation and cost efficiencies to drive future earnings growth, expecting improved sales in Consumer Care and Life Sciences in 2025.
More about Croda International
Croda International Plc operates in the specialty chemicals industry, focusing on creating high-performance ingredients and solutions that enhance lives. The company is known for its Consumer Care, Life Sciences, and Industrial Specialties segments, with a market focus on innovation and sustainable growth.
YTD Price Performance: -5.61%
Average Trading Volume: 453,623
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £4.46B
See more insights into CRDA stock on TipRanks’ Stock Analysis page.